T–cell–based immunotherapy for osteosarcoma: challenges and opportunities
AbstractEven though combining surgery with chemotherapy has significantly improved the prognosis of osteosarcoma patients, advanced, metastatic or recurrent osteosarcomas are often nonresponsive to chemotherapy, making development of novel efficient therapeutic methods an urgent need. Adoptive immun...
Main Authors: | Zhan Wang, Binghao Li, Yingqing Ren, Zhaoming Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00353/full |
Similar Items
-
Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma
by: Zenan Wang, et al.
Published: (2019-05-01) -
Advances on immunotherapy for osteosarcoma
by: Shengnan Yu, et al.
Published: (2024-09-01) -
New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
by: Cong Luo, et al.
Published: (2025-01-01) -
Targeted transcriptional profiling of the tumor microenvironment reveals lymphocyte exclusion and vascular dysfunction in metastatic osteosarcoma
by: Laurie Sorenson, et al.
Published: (2019-09-01) -
Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy
by: Jianshu Zhu, et al.
Published: (2023-09-01)